6 completed. 3 Phase 1, 3 Phase 2.
By phase and status
Follow BI 671800: new trials by email Literature Review of BI 671800 trials Research Report on BI 671800
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|
Single Rising Dose (SRD), Multiple Rising Dose (MRD) Study of BI 671800 in Healthy Asian Volunteers
BI 671800, placebo - Asthma, Rhinitis, Allergic, Perennial | Phase 1 | Completed | Boehringer Ingelheim | 73 | 2010-10-01 | 2013-11-19 |
Pharmacokinetics, Safety and Tolerability of BI 671800 HEA Given Over 7 Days. A Randomised, Double Blind, Placebo Controlled Within Dose Groups Phase I Study in Healthy Male and Female Volunteers.
Placebo, BI 671800 - Healthy | Phase 1 | Completed | Boehringer Ingelheim | 24 | 2010-10-01 | 2013-11-01 |
A Phase I Trial to Investigate the Metabolism and Pharmacokinetics as Well as Safety and Tolerability of a Single Dose BI671800 HEA Administered as an Oral Solution of the Choline Salt in Healthy Male Volunteers
BI 671800 - Healthy | Phase 1 | Completed | Boehringer Ingelheim | 8 | 2010-09-01 | 2013-11-01 |
BI 671800 in Asthmatic Patients on Inhaled Corticosteroids
BI 671800, Placebo, Montelukast - Asthma | Phase 2 | Completed | Boehringer Ingelheim | 243 | 2010-04-20 | 2022-05-31 |
BI 671800 ED in Steroid-naive Asthmatic Patients
BI 671800, Fluticasone propionate placebo, Fluticasone propionate - Asthma | Phase 2 | Completed | Boehringer Ingelheim | 389 | 2010-03-18 | 2022-05-31 |
Bi 671800 in Asthmatic Patients on Inhaled Corticosteroids
BI 671800, Placebo - Asthma | Phase 2 | Completed | Boehringer Ingelheim | 108 | 2010-03-01 | 2022-05-11 |
Conditions studied
Asthma (4) · Rhinitis, Allergic, Perennial (1)
Sponsors
Boehringer Ingelheim (6)
Countries
United States (4) · South Korea (3) · Germany (2) · New Zealand (2) · Australia (1) · Austria (1) · Canada (1) · Colombia (1) · Italy (1) · Mexico (1) · Peru (1) · Philippines (1) · Sweden (1) · Taiwan (1) · Turkey (Türkiye) (1)
NIH funding
2009 (3)